Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?

To: Mark Bartlett who wrote (13187)	12/11/2003 1:56:23 AM
From: jef saunders	Read Replies (1) \| Respond to of 14101

the problem with WF-10 is that it is a lab drug, not in the market. it's on the "back burner" at dimethaid, money is being spent on marketing pennsaid, not finishing WF-10. so it's safe to say WF-10 will not be coming out in 2003, nor 2004, nor 2005, and 2006 i'm starting to wonder about. i was very excited when dmx finished the WF-10 phase 3 trial. but now WF-10 is doomed to be in purgatory. when i saw dmx raise $10 million with the warrants, i was hoping that money would be used to complete WF-10. but it is not. it's all going to marketing Pennsaid. if i had cancer i'd go to Pugen right away. i hate to say that i wish dmx would dilute the stock or issue bonds to finish WF-10 but i do wish they would do whatever it takes for completion, instead of WF-10 sitting in limbo land. when will Pennsaid sales be big enough to fund WF-10 ? not 2004, i don't think in 2005 either. bums me out. jefS